Navigation Links
Novartis begins shipment of seasonal influenza vaccines to US market
Date:8/21/2013

d within 6 weeks of receipt of a prior influenza vaccine, the decision to give FLUCELVAX should be based on careful consideration of the potential benefits and risks.
  • Latex: The tip caps of the pre-filled syringes may contain natural rubber latex which may cause allergic reactions in latex-sensitive individuals.
  • Preventing and Managing Allergic Reactions: Appropriate medical treatment and supervision must be available to manage possible anaphylactic reactions following administration of the vaccine.
  • Altered Immunocompetence: After vaccination with FLUCELVAX, immunocompromised individuals, including those receiving immunosuppressive therapy, may have a reduced immune response.
  • Limitations of Vaccine Effectiveness: Vaccination with FLUCELVAX may not protect all vaccine recipients against influenza disease.
  • Most Common Adverse Reactions

    • The most common (>10 %) solicited adverse reactions occurring in adults 18-64 years of age within 7 days of vaccination with FLUCELVAX were pain at the injection site, erythema at the injection site, headache, fatigue, myalgia  and malaise.  The most common (>10%) solicited adverse reactions occurring in adults >65 years of age within 7 days of vaccination were erythema at the injection site, fatigue, headache and malaise.

    Disclaimer
    The foregoing release contains forward-looking statements that can be identified by terminology such as "begins," "plans," "offers," "has begun," "potential," "could," or similar expressions, or by express or implied discussions regarding potential future revenues from Fluvirin and Flucelvax. You should not place undue reliance on these statements.  Such forward-looking statements reflect the current views of management regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results
    '/>"/>

    SOURCE Novartis
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Novartiss Serelaxin Has the Potential to Fulfill the Most Pertinent Unmet Needs in Acute Heart Failure by Reducing the Rate of Patient Mortality and the Rate of Worsening Renal Function
    2. Novartis Breakthrough Therapy LDK378 shows a marked clinical response in patients with ALK+ non-small cell lung cancer
    3. Novartis Pharmaceuticals Corporation disputes allegations in two US Government lawsuits and looks forward to a fair discussion of the facts
    4. Novartis signs on to support Malaria No Mores Power of One campaign to stride towards a future without malaria
    5. Novartis Reports Omalizumab Significantly Improved Chronic Idiopathic Urticaria Symptoms in Patients Who Failed Standard Therapy
    6. Novartis Pharma Logistics, Inc. voluntarily recalling in Jamaica select lots of certain over-the-counter products due to bottle closure defect
    7. Novartis Pharma Logistics, Inc. voluntarily recalling in Trinidad & Tobago select lots of certain over-the-counter products due to bottle closure defect
    8. Novartis Pharma Logistics, Inc. voluntarily recalling in Curacao select lots of certain over-the-counter products due to bottle closure defect
    9. Novartis Pharma Logistics, Inc. voluntarily recalling in Aruba select lots of certain over-the-counter products due to bottle closure defect
    10. Novartis Pharma Logistics, Inc. voluntarily recalling in Barbados select lots of certain over-the-counter products due to bottle closure defect
    11. Continued Uptake of Novartis/Incytes Jakafi Will Be the Greatest Driver of Growth in the Myelofibrosis Therapy Market
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/28/2015)... , Aug. 28, 2015  Perrigo Company plc ("Perrigo") ... has completed the acquisition of leading OTC brands from ... million. The transaction is a clear demonstration of Perrigo,s ... leading European distribution network spanning 36 countries.  ... Papa commented, "We are excited to complete this ...
    (Date:8/28/2015)... Massachusetts y LONDRES, 28 de agosto ... AEX: PHIA) anunció hoy su participación en el  ... exhibirá sus soluciones cardiológicas más recientes y novedosas, ... Cardiovascular, que conectan a las personas y la ... de ayudar a diagnosticar, guiar los tratamientos y ...
    (Date:8/27/2015)... DURECT Corporation (Nasdaq: DRRX ) announced ... upcoming healthcare conferences.  , James ... the Rodman & Renshaw Investment Conference on Thursday, September ... being held at the St. Regis Hotel in ... webcast of the presentation will be available by accessing ...
    Breaking Medicine Technology:Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 3Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 5DURECT to Participate in Upcoming Healthcare Conferences 2
    ... PharmaTech (Cayman) Inc. (NYSE: WX ) ... general meeting of shareholders held in Hong Kong ... (Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO ) ... re-election of incumbent Class C directors Dr. Ge ...
    ... -Asia/ -- Winner Medical Group Inc. (Nasdaq: ... dressings, medical disposables and non-woven PurCotton® materials for the ... preliminary, unaudited financial results for its fiscal fourth quarter ... fourth quarter and year ended results are unaudited and ...
    Cached Medicine Technology:WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2010 Annual General Meeting 2Winner Medical Announces Preliminary Fiscal Fourth Quarter 2010 Results 2Winner Medical Announces Preliminary Fiscal Fourth Quarter 2010 Results 3Winner Medical Announces Preliminary Fiscal Fourth Quarter 2010 Results 4Winner Medical Announces Preliminary Fiscal Fourth Quarter 2010 Results 5
    (Date:8/29/2015)... ... August 29, 2015 , ... It can be uncomfortable to ... urine and sweat. "In order to prevent these problems, I conceived of my ... ENHANCED MEN'S UNDERGARMENT provides optimal support for a male’s crotch. It improves comfort ...
    (Date:8/29/2015)... ... ... Brands like Toppik , Eau Thermale Avene and Bliss are now ... of $49.00 was required to qualify for free standard shipping,” said Jennifer Ramirez, the ... customers regardless of the item’s selling price.” , With competitive pricing in the e-commerce ...
    (Date:8/29/2015)... Calgary, AB (PRWEB) , ... August 29, 2015 ... ... congestive heart failure, angina, chronic obstructive pulmonary disease (including emphysema), or asthma, are ... conditions such as angina, previous heart attack, heart failure or heart-rhythm problems (arrhythmia ...
    (Date:8/29/2015)... (PRWEB) , ... August 29, 2015 , ... ... the company to freely market and sell Arterosil and Arterosil HP, and that ... Sciences, LLC (DHS) sued Vascular Health Sciences, LLC (VHS) in the United States ...
    (Date:8/28/2015)... ... , ... An online provider of CPAP machines, masks, supplies, and accessories, My ... affordable by offering shipping at no cost to you, directly to your door on ... size. My Cpap Store is located in Las Vegas, Nevada. , Sleep apnea is ...
    Breaking Medicine News(10 mins):Health News:Modified Men’s Underwear Promote More Comfort and Hygiene - Designed by InventHelp Client (LGI-1968) 2Health News:TheBeautyPlace.com Discounts Shipping on Select Brands 2Health News:Heart Fit Clinic Sounds the Alarm on Forest Fire Smoke and Chronic Heart Disease in Calgary Area 2Health News:My Cpap Store Now Offering Delivery Special 0 Cost to You 2
    ... Institute (SERI) found that increasing the contrast of details ... the visually impaired. // ,The U.S. study provides ... help millions suffering eye diseases. People who may benefit ... degeneration, diabetic retinopathy and other causes of low vision. ...
    ... family and community medicine and colleagues developed the latest tool ... developed a tool which is called the Newest vital sign. ... based on an ice cream nutrition label. Based on the ... literacy can be calculated. , Then it is ...
    ... Canada the sex workers feel that the Canadian Law which does ... their customers in public and does not allow to do sex ... workers organization feels that the law will not help the sex ... as they are not sure about the place of business and ...
    ... transplant at the St James's University Hospital in Leeds, as a ... long as 10 hours, in which half the liver of the ... liver problems and jaundice within weeks after his birth. His bile ... to be the only way of saving his life. The parents ...
    ... Researchers in San Diego have designed mice containing fully functional ... potentially treat neurodegenerative diseases such as Parkinson's and Alzheimer's. // ... La Jolla, the neurons were formed in the brains of ... as 2-week-old embryos. ,Studies showed that the ...
    ... get relief from chronic discomfort, according to recent research studies ... eight patients were taught to reduce pain through showing them ... Standard therapy has not been very successful while treating chronic ... of the research. People can be trained to change the ...
    Cached Medicine News:Health News:Visually impaired prefer specially enhanced TV 2Health News:Visually impaired prefer specially enhanced TV 3Health News:Human neurons grown in the brains of mice 2
    Grab one and go, One of the smallest handheld oximeters available, Datex-Ohmeda s TuffSat is the ideal spot-check solution for hospital, home care, transport, and EMS. TuffSat comes fully loaded wi...
    The Stat Profile pHOx CO-Oximeter is intended for use in those situations where a more comprehensive profile beyond the measured hematocrit, hemoglobin, and SO2% offered by the Stat Profile pHOx ...
    Smith & Nephew's CDS System is developed exclusively for discography., Developed exclusively for discography, it is the first system designed to measure true disc pressure and record real-time proce...
    Maxi-Therm® hyper-hypothermia water blankets from Cincinnati Sub-Zero are designed for single-patient use. These blankets are easy to clean, stain resistant and ideal for isolation cases....
    Medicine Products: